These results were in conflict with the observed low expression of NEK7, NLRP3, and ASC, and suggests that the expression of Caspase-1 in PBMCs from SLE patients is not only affected by NLRP3 inflammasome signaling, but also by other signaling pathways. This evidence concerns the gene NLRP3 and systemic lupus erythematosus.